Synthesis of Cytotoxic 2,2-Difluoroderivatives of Dihydrobetulinic Acid and Allobetulin and Study of their Impact on Cancer Cells
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F15%3A33156128" target="_blank" >RIV/61989592:15110/15:33156128 - isvavai.cz</a>
Alternative codes found
RIV/68407700:21340/15:00227815 RIV/00216208:11310/15:10315850 RIV/61989592:15310/15:33156128
Result on the web
<a href="http://www.sciencedirect.com/science/article/pii/S0223523415002433" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0223523415002433</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ejmech.2015.03.068" target="_blank" >10.1016/j.ejmech.2015.03.068</a>
Alternative languages
Result language
angličtina
Original language name
Synthesis of Cytotoxic 2,2-Difluoroderivatives of Dihydrobetulinic Acid and Allobetulin and Study of their Impact on Cancer Cells
Original language description
In this article, we describe the preparation and cytotoxic properties of a small focused library of lupane and 18α-oleanane triterpenoids that contain a combination of two structural motifs known to enhance the biological activities. First, we introduced two fluorine atoms to position 2 of the skeleton. Second, we synthesized a set of hemiester prodrugs, which were intended to increase the solubility and activity. Starting from betulin, we obtained two hydroxyketones (derivatives of dihydrobetulinic acid and allobetulin) and their fluorination using DAST provided 2,2-difluoro-3-oxo-compounds as the main products. Then the 3-oxo group in each derivative was reduced by NaBH4 to obtain 3β-hydroxy compounds suitable for modifying by various hemiesters. We prepared 21 compounds, 11 of them new, their cytotoxicity was tested on T lymphoblastic leukemia CCRF-CEM cells first and the most active derivatives were selected for screening on another six tumor and two non-tumor cell lines. All of them showed selectivity against cancer lines with therapeutic index between 2 and 8. All hemiesters had activity in the same range as the free hydroxyl derivatives and they would be suitable prodrugs for future in vivo experiments. Interestingly, all hemiesters of 2,2-difluorodihydrobetulonic acid had higher activity against p53 knock-out p53-/- cancer cell line than against the non-mutated analogue. In active derivatives, the cell cycle was analyzed by flow cytometry and several compounds slowed down cell cycle progression through G0 /G1 or S-phase.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
CC - Organic chemistry
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
European Journal of Medicinal Chemistry
ISSN
0223-5234
e-ISSN
—
Volume of the periodical
96
Issue of the periodical within the volume
MAY
Country of publishing house
FR - FRANCE
Number of pages
9
Pages from-to
482-490
UT code for WoS article
000355712500044
EID of the result in the Scopus database
—